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Introduction. Preoperative malnutrition is a major risk factor for increased postoperative morbidity and mortality. Definition and
diagnosis of malnutrition and its treatment is still subject for controversy. Furthermore, practical implementation of nutrition-
related guidelines is unknown. Methods. A review of the available literature and of current guidelines on perioperative nutrition
was conducted. We focused on nutritional screening and perioperative nutrition in patients undergoing digestive surgery, and
we assessed translation of recent guidelines in clinical practice. Results and Conclusions. Malnutrition is a well-recognized risk
factor for poor postoperative outcome. The prevalence of malnutrition depends largely on its definition; about 40% of patients
undergoingmajor surgery fulfil current diagnostic criteria of being at nutritional risk. TheNutritional Risk Score is a pragmatic and
validated tool to identify patients who should benefit from nutritional support. Adequate nutritional intervention entails reduced
(infectious) complications, hospital stay, and costs. Preoperative oral supplementation of a minimum of five days is preferable;
depending on the patient and the type of surgery, immune-enhancing formulas are recommended. However, surgeons’ compliance
with evidence-based guidelines remains poor and eﬀorts are necessary to implement routine nutritional screening and nutritional
support.
1. Introduction
The World Health Organization cites malnutrition as the
greatest single threat to the world’s public health. Indeed,
the reported in-hospital prevalence of malnourished patients
on admission ranges up to 50% [1–5]. Increasing evidence
has been accumulated during recent years that nutritional
screening and therapy are important adjuncts inmodern sur-
gical care since up to 40% of patients are at nutritional risk
preoperatively [6–8]. Malnutrition before gastrointestinal
(GI) surgery is caused by decreased oral food intake, preex-
isting chronic disease, tumour cachexia, impaired absorption
due to intestinal obstruction, and previous surgical bowel
resection. Moreover, low socioeconomical status, as often
seen in elderly and handicapped patients, represents an addi-
tional risk factor [7, 9].
Malnourished patients have a significantly higher mor-
bidity and mortality, a longer length of stay (LOS) and
increased hospital costs [1, 6, 7, 10, 11]. Perioperative
nutrition has been convincingly shown to improve clinical
outcome in patients undergoing major GI surgery and to
reduce costs [1, 12]. The mechanism of action seems to be
not only an improved nutritional status by providing a higher
caloric intake, but primarily a reenforced immune response;
nutritional formulas containing immune-modulating agents
(glutamine, arginine, n-3 fatty acids, and ribonucleic acids)
are particularly beneficial modulators of the acute stress
response [13, 14]. Various original studies and compre-
hensive guidelines have been issued recently to define pre-
operative screening and to standardize perioperative nutri-
tion with regard to mode, timing, duration, and formula
[15]. Furthermore, there are only scarce data assessing the
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practical implementation of these evidence-based recom-
mendations.
The aim of this study was to assess the current evidence
for nutritional screening as well as perioperative nutrition in
major abdominal surgery and its implementation in daily
clinical practice. Furthermore, a pragmatic algorithm for evi-
dence-based perioperative nutrition is provided.
2. Methods
2.1. Data Sources and Search Strategies. Relevant articles were
identified searching Medline (through PubMed) by use of
the appropriate MeSH terms for the following search items:
malnutrition, nutritional screening, nutritional risk, peri-
operative (pre-, postoperative) nutrition (oral, enteral, and
parenteral), immunonutrition, practical implementation of
nutritional screening, and supporting ANDmajor GI surgery
AND clinical outcome (complications, mortality, andhospi-
tal stay). Hand-searched electronic links and references of
selected articles were cross-checked. The search was limited
to studies published between January 1980 and June 2010
as no frequently cited milestone articles on perioperative
nutrition have been published before. Only articles published
in English were considered eligible [16].
2.2. Study Selection. We privileged systematic reviews and
meta-analyses from high-impact peer-reviewed journals
and recent evidence-based guidelines. Further, important
original studies adding complementary information were
included. Selected studies had to treat the clinical impact of
either (i) malnutrition, or (ii) nutritional screening (iii), or
perioperative nutrition, or (iv) the practical implementation
of nutritional screening and support in digestive surgery. For
each of these areas, two authors independently performed
the literature search; studies of interest were identified by
screening of title, abstract, or medical subject headings. Final
decision on inclusion was made based on the full text articles
by the entire research team.
3. Results
The electronic search of the literature identified more than
a thousand possible hits. These were carefully screened, and
irrelevant studies were excluded by title, abstract, or full
text analysis. Covering a large thematic array, many eligible
studies fulfilled the inclusion criteria. Therefore, a further
selection was necessary based on quality and importance
for our aims. Finally, we included 68 publications, of those,
14 reviews/guidelines and 36 randomized controlled trials
have been identified as major contributions to the field of
perioperative nutrition.
3.1. Definition and Diagnosis of Malnutrition. Since there
are no standardized and widely accepted definitions, precise
diagnosis of malnutrition remains diﬃcult. This major
methodological shortcoming contributes to the heterogene-
ity of studies and also impairs proper assessment of mal-
nutrition in daily clinical practice. Diagnostic criteria range
from simple patient’s data, such as amount of food intake,
weight loss [18], or body mass index, to biochemical markers
(albumin [19], prealbumin [20]) or various physiologic
assessments. In order to develop simple, reliable, and repro-
ducible screening tools, these parameter are often combined
in scores (i.e., nutritional risk index (NRI) [21]) to grade
the severity of malnutrition. Questionnaires such as the
subjective global assessment (SGA) [22] are also described.
Biometrical analyses, such as the phase angle (PA) [23] which
quantifies body leanmass and fat by electrical impedance, are
less frequently used (Table 2).
The most valuable tool for nutritional screening for sur-
gical patients is currently the Nutritional Risk Score (NRS)
that is oﬃcially recommended by the European Society of
Parenteral and Enteral Nutrition (ESPEN) [17]. It is based
on the amount of malnutrition, as defined by weight loss,
food intake, and BMI, as well as on the severity of disease
(Table 1). Its predictive value was validated by applying it
to a retrospectively 128 RCTs on nutritional support [17]
and prospectively in a cohort including 5051 hospitalized
patients in 12 European Countries and 26 diﬀerent surgical
centers [8]. The NRS used retrospectively was able to
distinguish between trials with a positive eﬀect of perioper-
ative nutritional support versus those with no eﬀect. When
applied prospectively, it showed that “at-risk” patients had
more complications, higher mortality, and longer lengths
of stay than “not-at-risk” patients, and these variables
were significantly related to components of NRS-2002, also
when adjusted for confounders. The prevalence reported of
patients at risk evaluated by NRS varies in literature from 14
to 32.6% [7, 8, 24].
Since the objective in diagnosing malnutrition is to treat
it as early as possible in order to improve patient’s outcome,
screening tools have to be correlated to postoperative
outcome. In the comparison of Antoun et al., who evalu-
ated several screening system, only serum albumin <30 g/L
showed a significant association to postoperative morbidity
after multivariate analysis [19]. Schiesser et al. undertook a
comparison between the NRS, NRI, and PA. These methods
were well correlated for diagnosis of malnutrition. Moreover,
they had a predictive value for postoperative complications.
The strongest correlation for the diagnosis of malnutrition
was found between NRS and NRI, but only NRS was able
to reliably predict postoperative morbidity after multiple
regression analysis [23].
3.2. Treatment of Malnutrition. Perioperative malnutrition is
considered as a modifiable and treatable cause of postopera-
tive morbidity [25, 26]. While nutritional support has shown
to reduce infections, complications, LOS, and costs [27–29],
many questions remain concerning patient selection, timing,
route of administration, and type of nutritional support
remains to be elucidated.
3.2.1. Patient Selection. Patients are considered to be at
severe nutritional risk if the NRS is ≥3 or if at least one
of the following criteria is fulfilled: weight loss of 10–
15% within 6 months, BMI < 18.5 kg/m2, Subjective Global
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Table 1: Nutritional Risk Screening score (NRS 2002) [17]. The total score is obtained by adding the nutritional score to the disease score.
Age > 70 years adds 1 to the total score. If age-corrected total is ≥3, the patient presents severe malnutrition, and nutritional support is
recommended.
Malnutrition
Mild Moderate Severe
Score 1 Score 2 Score 3
Nutritional
Status
BMI (kg/m2) — 18.5–20.5 <18.5
Food Intake (%) 50–70 25–50 <25
Weight loss <5% 3 months 2 months 1 month
Disease
severity
Example
Hip fracture, cirrhosis,
COPD
Major surgerya, Stroke
Head injury, bone marrow
transplantation, ICU
patients (APACHE 20)
Age (Years) >70
a
Major abdominal surgery includes colorectal, gastric, liver, pancreatic, and esophageal resection for benign and malignant disease by either laparotomy or
laparoscopic approach, lasting usually >2 h.
Table 2: Overview on common screening tools for malnutrition and its reported prevalence depending on study and screening tool.
Antoun et al. Schiesser et al.
Malnutrition Weight loss BMI (kg/m2) SGA
Albumin
(g/L)
NRI NRS (2002)∗∗ PA NRI
None — (29%)1 18.5–25 (50%)1 A (66%)1 >35 >97.5 (59%)1 Score 0 >6◦ (71%)2 >97.5 (85%)2
Mild <10% (39%)1 <18.5 (8%)1
B (22%)1 <35 (24%)1
84–97.5
(32%)1
Score 1 (89%)2
<6◦ (28%)2
84–97.5
(13%)2Moderate Score 2 (8.5%)2
Severe ≥10% (20.5%)1 <16 (2%)1 C (12%)1 <30 (8%)1 <84 (9%)1 Score 3 (2.5%)2 <84 (2%)2
BMI: body mas index (kg/m2); SGA: subjective global assessment (weight, food intake, symptoms, and activities); NRI: nutritional risk index (recent weight
loss, serum albumin); NRS (2002): nutritional risk screening score (Table 2); PA: phase angle (reactance and resistance from bioimpedance analysis).
1Antoun et al. [18] (prevalence %).
2Schiesser et al. [23] (prevalence %).
∗∗Nutrition status score only.
Assessment Grade C or Serum albumin <30 g/L [26, 30].
For these patients, major surgery should be postponed until
nutritional status has been corrected [26].
Most patients with GI cancer have severe malnutrition
preoperatively and their immunological function is sup-
pressed. Moreover, prolonged postoperative fasting and in-
suﬃcient oral food intake may worsen preexisting malnu-
trition. Hence, there is an increased risk of postoperative
complication, and all patients should therefore benefit from
perioperative nutrition prior to major oncological surgery
[29].
When the NRS is used, patients, with a score of 3 or more
are prone to develop postoperative complications and should
benefit from nutritional support [8, 23]. Since age directly
influences the NRS [15], elderly patients (>70 years) must
be considered as at particular risk [8]. Nutritional profile
of these patients is a good prognostic factor and eﬀorts
should be made to maintain an optimal nutritional status
[31].
It has been shown that even in wellnourished patients,
peripoperative nutritional support positively influences
postoperative outcome [25]. Enhanced recovery programs
have developed for such patients, with a particular focus to
minimizing preoperative fasting period and maximizing
carbohydrate loading [32].
3.2.2. Timing of Nutrition. The role of preoperative nutri-
tional support is to improve undernutrition before surgery,
while postoperative nutrition aims at maintaining nutri-
tional status in the catabolic period after surgery. The timing
of nutritional support is widely debated. While conventional
enteral nutritional support is recommended for 10–14 days
prior to major surgery in patients with severe nutritional
risk to improve the nutritional state, immunonutrition (IN)
is administered for 5–7 days prior to surgery to all cancer
patients in order to improve immune function [26].
Although preoperative fasting has long been considered
as a dogma, Brady et al. showed that a 2-hour fasting for
clear fluids does not increase complications [33]. Nowadays,
a preoperative fasting of 2 hours for fluids and 6 hours for
solid food is considered as best practice and recommended
by the ERAS (Enhanced Recovery After Surgery) group [32].
Postoperatively, normal oral food intake or nutrition
through feeding tube should start within the first 24 hours.
A recent meta-analysis evaluated early commencement of
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postoperative enteral nutrition (within 24 h) versus tradi-
tional management in patients undergoing gastrointestinal
surgery. It was in favour of early enteral feeding following
gastrointestinal surgery to reduce morbidity and mortality
rates [34, 35]. The beneficial eﬀect of early oral feeding was
also shown by El Nakeeb et al. [36]. There is strong evidence
that oral nutritional supplements (200mL twice daily) given
from the day of surgery until normal food intake is achieved
are beneficial.
While perioperative nutritional support is recommend-
ed, some studies suggest that nutrition limited to the pre-
operative phase might have the same beneficial eﬀects than
combined pre- and postoperative nutrition. As far as IN is
concerned, three RCTs have found no diﬀerence when com-
paring pre- and perioperative IN patients [13, 18, 25].
Another study compared IN given perioperatively with con-
trol patients receiving IN only postoperatively [37]. A signif-
icant decrease in postoperative complications is seen in the
perioperative IN group compared to the postoperative IN
group.
The optimal duration of nutritional support in the post-
operative period remains unclear. While using postoperative
oral nutritional supplements for 8 weeks in malnourished
patients enhances recovery of nutritional status and quality
of life [38], benefits for well-nourished patients are less
evident [39]. Concerning postoperative IN, duration of
therapy varied from 3 [40] to more than 10 days [18, 25, 41–
45], with the most common duration being 7 days [13, 46–
51].
3.2.3. Route of Administration. Basically, nutritional support,
with or without regular oral diet, can be administered in
three ways: orally as oral nutritional supplements (ONSs),
enterally through a feeding tube, or parenterally. As stated
in the ESPEN 2006 guidelines, the enteral route should
always be preferred bar if intestinal obstruction, severe shock
or intestinal ischemia is present. Stratton and Elia showed
that both oral nutritional supplements (ONSs) and feeding
tube nutrition (FTN) were able to reduce postoperative
complications in gastrointestinal (GI) surgical patients, when
compared to routine care nutrition alone. However they had
no influence on mortality [27]. When FTN was compared to
parenteral nutrition in cancer patients undergoing surgery,
those receiving enteral nutritional support had significantly
less infectious complications.
Lassen et al. studied the postoperative outcome of
patients undergoing major upper GI surgery. Those allowed
to eat at will had less complications and shorter hospital
stay than patients fed through a needle-catheter jejunostomy
[52].
3.2.4. Type of Supplementation. A whole variety of nutri-
tional supplementation was identified through the electronic
database search.
There is strong evidence that clear carbohydrate-rich
beverage administration before midnight and 2 to 3 hours
before colonic surgery ameliorates pre- and postoperative
patient’s status, accelerates, recovery and shortens hospital
stay [32].
Immunonutrition, which contains a combination of glu-
tamine, arginine, n-3 fatty acids, and RNA, has been eval-
uated in numerous studies [13, 25, 29, 41, 43, 46, 47, 50,
51, 53, 54]. A recent meta-analysis assessed the impact of
IN on postoperative complications, in particular infectious
complications, length of hospital, stay and mortality in
patients undergoing major GI surgery. Twenty-one RCTs
enrolling a total of 2730 patients were included in the
meta-analysis. IN significantly reduced overall complications
when used preoperatively, perioperative, or postoperatively.
Patients receiving IN had less infection. The mean diﬀerence
in LOS favoured IN (−2.12 (95% CI −2.97, −1.26) days).
However, perioperative IN had no influence on mortality
(submitted data). In all of the 9 RCTs evaluating preoperative
IN, duration of supplementation was within the 5–7 days
recommended range [13, 18, 25, 29, 40, 46, 55–57].
When each component of IN was studied separately,
disparity was observed in the results.
Jiang et al. compared cancer patients receiving omega
3 supplementation postoperatively for 7 days to patients
receiving an isocaloric isonitrogenous diet. They found a
lower incidence of infectious complications and a shorter
length of stay in the treatment group. However, no significant
diﬀerence could be demonstrated as far as costs are con-
cerned [58]. A meta-analysis showed a decrease in infection
rate, but no advantage in LOS or mortality [59].
While Sun et al. demonstrated that branched chain
amino acid enriched total parenteral nutrition reduced post-
operative complications in malnourished patients with gas-
trointestinal cancer undergoing major surgery [60], Gianotti
et al. failed to improve the clinical outcome of patients
receiving perioperative amino acids [61]. In another RCT,
parenteral glutamine supplementation in the preoperative
period failed to decrease infection rate, wound complication,
days in the intensive care unit, and mortality [62].
3.3. Implementation of Current Guidelines in Clinical Practice.
Implementation of nutritional support strategies into daily
clinical practice encounters many diﬃculties and consider-
able eﬀorts are needed to be successful. It has been shown
in several studies that malnutrition is either not recognized
or not viewed as clinically significant and that appropriate
interventions are not considered necessary [3, 11].
A recent one-day multinational cross-sectional European
audit showed that instruments used to identify undernour-
ished patients and those at risk diﬀer widely. Often, national
and validated tools are replaced with locally developed
ones. Many countries do not implement the recommended
screening policy, which leads to underdiagnosis and under-
treatment of malnutrition [63].
Our group conducted a survey among Swiss and Aus-
trian public hospitals in order to get information about
implementation of the above-mentioned current guidelines.
We inquired about nutritional screening and therapy and
appraisal of current evidence of perioperative nutritional
support.
Conforming to previous data, we observed that imple-
mentation of current guidelines was modest at best. Only
20% of the participating centres routinely screened their
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Postpone surgery
oral/enteral nutrition
2 weeks pre-op
5–7days pre-op:
Immunonutrition
5–7days
pre-op:
SEN
5–7days
pre-op:
IN
Surgery within enhanced recovery protocols if available
consider placement of percutaneous or nasoenteral nutritional catheters if
A prolonged postoperative fasting or
B insuﬃcient food intake probable
Severe
malnutrition?
1
2
3
+
+
+
+
−
−
−
−
4
∗
Routine nutritional screening by use of the NRS
if severe malnutrition is suspected: additional clinical and laboratory parameters
Early post-op food intake within
enhanced recovery protocols if
available, consider oral supplements
Consider preferentially enteral or if
contraindicatedf parenteral nutrition until
suﬃcient food intake is assured
High probability of
A prolonged postoperative fasting or
B insuﬃcient food intake ?c
NRS ≥ 3?
3×
No!
Major upper GI
cancer surgery?b
All patients before major abdominal surgerya
Figure 1: Pragmatic algorithm for preoperative nutritional screening and perioperative nutrition in digestive surgery. The algorithm resumes
perioperative care in terms of nutrition in major abdominal surgery. It is largely based on recent systematic reviews and guidelines on
perioperative nutrition [26, 27] and enhanced recovery [32]. aMajor abdominal surgery includes colorectal, gastric, liver, pancreatic, and
esophageal resection for benign and malignant disease by either laparotomy or laparoscopic approach, lasting usually >2 h. bMajor upper
GI surgery indicating preoperative IN regardless of nutritional status include oesophageal, gastric and pancreatic resection for cancer [26].
cdefined as anticipated perioperative starving >7 days and oral intake <60% of recommended for >10 days [26]. NRS: Nutritional Risk
Score; pre-OP: pre-operative, IN: immunonutrition, SEN: standard enteral nutrition (usually whole protein formula). ∗currently evaluated
by (http://www.clinicaltrial.gov; trial # NCT005122).
GI surgery patients for nutritional status. Great disparities
existed regarding screening methods. Approximately two
thirds of centres were using various combinations of clinical
and laboratory parameters to assess patients’ nutritional
status. In our study, theNRSwas only used by 14% of centres.
Nutritional treatment was part of perioperative care in
about 70% of all centres, and mostly dedicated to cancer
patients or patients undergoing major surgery rather than to
patients previously screened for their nutritional risk.
Overall, about two thirds of all centres estimated that
there is enough scientific evidence in favour of preoper-
ative nutritional support. Reduced complication rates and
decreased length of hospital stay were acknowledged asmajor
advantages. Logistic and financial issues were mentioned as
reasons against the implementation of nutritional support in
daily clinical practice (submitted data).
4. Discussion
The present paper summarizes the current evidence on pre-
operative nutritional screening and perioperative nutrition
in major abdominal surgery. Malnutrition is a common
problem in GI surgery patients (40%) and doubtlessly one
of the most important risk factors for postoperative compli-
cations. The NRS is a validated screening tool that reliably
identifies patients at nutritional risk who benefit from a
nutritional supplementation. Recent high-quality studies
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have delivered convincing evidence that perioperative nutri-
tion is a highly eﬀective treatment that entails reduced com-
plications, hospital stay, and costs. Most impressive results
have been obtained by preoperative administration of im-
munonutrition.
The recent data permitted to issue actual evidence-
based guidelines in an attempt to standardize perioperative
nutrition in abdominal surgery. We outlined, however, that
implementation of these recommendations is not satisfac-
tory.
In a recent survey (unpublished data), most responding
surgeons acknowledged clearly the positive impact of peri-
operative nutrition on postoperative outcome. Nevertheless,
cost issues for outpatient nutrition and time restraints are
obviously prominent reasons against nutritional care. The
formation of specialized multidisciplinary teams failed to
improve nutritional care. It can be therefore assumed that
the individual surgeon is the most straightforward way to
increase adherence to nutritional guidelines!
Based on the current literature and guidelines, we pro-
pose a simple and pragmatic algorithm for preoperative
nutritional screening and perioperative nutritional therapy
(Figure 1). All patients undergoing major surgery should
be screened for malnutrition. Depending on the degree of
malnutrition and the type of surgery, nutritional support
should start within 14–7 days preoperatively. If insuﬃcient
postoperative food intake is anticipated, early enteral tube
feeding should be started.
In conclusion, malnutrition is a well-known major risk
factor for poor postoperative outcome. Preoperative nutri-
tional screening is therefore mandatory to identify patients
who need perioperative nutritional support. For most
patients, a preoperative oral supplementation by whole pro-
tein formulas or immunonutrition is suﬃcient. The proven
benefits for the patients justify the considerable eﬀorts to fo-
ster implementation of these current guidelines in clinical
practice.
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